Neuberger Berman High Yield Strategies Fund Inc. (NHS)
- Previous Close
7.93 - Open
7.92 - Bid --
- Ask --
- Day's Range
7.91 - 7.95 - 52 Week Range
6.95 - 9.13 - Volume
78,953 - Avg. Volume
96,461 - Market Cap (intraday)
206.164M - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
49.69 - EPS (TTM)
0.16 - Earnings Date --
- Forward Dividend & Yield 1.09 (13.66%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
--
Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.
www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: NHS
Performance Overview: NHS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NHS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NHS
Valuation Measures
Market Cap
206.16M
Enterprise Value
--
Trailing P/E
49.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
21.16
Price/Book (mrq)
1.06
Enterprise Value/Revenue
23.69
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
16.63%
Return on Assets (ttm)
4.13%
Return on Equity (ttm)
2.05%
Revenue (ttm)
22.35M
Net Income Avi to Common (ttm)
3.72M
Diluted EPS (ttm)
0.16
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
54.48%
Levered Free Cash Flow (ttm)
3.1M
Company Insights: NHS
NHS does not have Company Insights